糊精(8-370)(人)
|
|
|
- CAS号:
- 135702-23-7
- 英文名:
- AMYLIN (8-37) (HUMAN)
- 英文别名:
- Human amylin 8-37;AMYLIN (8-37) (HUMAN);Amylin (8-37), amide, rat;amylin fragment 8-37 amide;AMYLIN FRAGMENT 8-37 HUMAN;AMYLIN (8-37) (HUMAN) USP/EP/BP;ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2;diabetes associated peptide fragment 8-37 amide;Diabetes associated peptide fragment 8-37 amide, ≥97% (HPLC);Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
- 中文名:
- 糊精(8-370)(人)
- 中文别名:
- 胰淀素(8-37);糊精(8-37)(人);糊精(8-370)(人);人胰淀素(淀粉样肽)8-37;糊精(8-37)(人), ≥97% (HPLC)
- CBNumber:
- CB0191689
- 分子式:
- C138H216N42O45
- 分子量:
- 3183.45
- MOL File:
- 135702-23-7.mol
|
|
|
糊精(8-370)(人)化学性质
-
密度:
-
1.51±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
−20°C
-
|
-
形态:
-
Solid
-
|
糊精(8-370)(人)性质、用途与生产工艺
Amylin (8-37), human 是人胰淀素的一个片段。Amylin (8-37), human 在大鼠离体肠系膜阻力动脉中表现出直接的血管舒张作用。人胰淀素是一种由胰腺 β 细胞分泌的小激素，会在胰岛素缺乏的代谢条件下形成聚集物，是 II 型糖尿病的病理特征。
糊精(8-370)(人)
上下游产品信息
上游原料
下游产品
135702-23-7, 糊精(8-370)(人) 相关搜索:
- Peptide
- 目录多肽
- 目录肽
- 细胞信号和神经生物学
- 多肽
- 细胞生物学
- Obesity Peptides
- Peptides
- Amylins
- Biochemicals and Reagents
- Amino Acids and Peptides
- BioChemical
- C138H216N42O45
- 人胰淀素(淀粉样肽)8-37
- 糊精(8-37)(人), ≥97% (HPLC)
- 糊精(8-37)(人)
- 糊精(8-370)(人)
- 胰淀素(8-37)
- 135702-23-7
- AMYLIN (8-37) (HUMAN) USP/EP/BP
- L-Tyrosinamide, L-alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-asparaginyl-L-phenylalanyl-L-leucyl-L-valyl-L-histidyl-L-seryl-L-seryl-L-asparaginyl-L-asparaginyl-L-phenylalanylglycyl-L-alanyl-L-isoleucyl-L-leucyl-L-seryl-L-seryl-L-threonyl-L-asparaginyl-L-valylglycyl-L-seryl-L-aspara...
- Diabetes associated peptide fragment 8-37 amide, ≥97% (HPLC)
- Amylin (8-37) (human) trifluoroacetate salt H-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 trifluoroacetate salt
- Amylin (8-37), amide, rat
- L-Alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-asparaginyl-L-phenylalanyl-L-leucyl-L-valyl-L-histidyl-L-seryl-L-seryl-L-asparaginyl-L-asparaginyl-L-phenylalanylglycyl-L-alanyl-L-isoleucyl-L-leucyl-L-seryl-L-seryl-L-threonyl-L-asparaginyl-L-valylglycyl-L-seryl-L-asparaginyl-L-threonyl-L-tyrosinamide
- Human amylin 8-37
- Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
- LYS-CYS-ASN-THR-ALA-THR-CYS-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2: KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2DISULFIDE BRIDGE CYS2-CYS7
- diabetes associated peptide fragment 8-37 amide
- amylin fragment 8-37 amide
- AMYLIN FRAGMENT 8-37 HUMAN
- AMYLIN (8-37) (HUMAN)
- H-ALA-THR-GLN-ARG-LEU-ALA-ASN-PHE-LEU-VAL-HIS-SER-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-THR-ASN-VAL-GLY-SER-ASN-THR-TYR-NH2
- ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2